Donald Trump's threat of 25% or more tariffs on pharmaceuticals imported to the US would be a bitter pill to swallow for both consumers and producers, as costs will increase particularly in the short run
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,